A Molecular Characterization of Drugs, Their Targets and Biological Effects within Lung Cancer to Facilitate New Treatment Paradigms  Page description

Help  Print 
Back »

 

Details of project

 
Identifier
121510
Type KNN
Principal investigator Szász, Attila Marcell
Title in Hungarian Új hatóanyagok, célpontjaik és biológiai hatásuk karakterizálása tüdőtumorokban, terápiás eljárások kidolgozására
Title in English A Molecular Characterization of Drugs, Their Targets and Biological Effects within Lung Cancer to Facilitate New Treatment Paradigms
Keywords in Hungarian tirozin kináz inhibitor, tüdőrák, tömegspektrométer
Keywords in English tyrosin kinase inhibitor, lung cancer, mass spectormetry
Discipline
Cancer and its biological basis (Council of Medical and Biological Sciences)70 %
Public health, health services, environmental and occupational medicine, epidemiology, medical ethics (Council of Medical and Biological Sciences)15 %
Ortelius classification: Anticancer therapy
Clinical pharmacology, gene therapy, cell therapy, regenerative medicine (Council of Medical and Biological Sciences)15 %
Panel Immunity, Cancer and Microbiology
Department or equivalent Koranyi National Institute for Pulmonology
Participants Döme, Balázs
Moldvay, Judit
Ostoros, Gyula
Starting date 2017-10-01
Closing date 2020-12-31
Funding (in million HUF) 36.212
FTE (full time equivalent) 4.00
state running project




Back »